Become an Incathlab member and receive full access to its content!
Registration Login
Healthcare systems are facing a huge rise in demand for emergency room visits, ward admissions and ICU entries. Despite medical departments reforms and clinical appointments rescheduling, critical status patients with life-threatening severe aortic stenosis and other conditions are being postponed.
This situation poses unique challenges to the care of non-COVID patients and interventional community is worried. A concerted strategy to mitigate the effects of COVID-19 in structural heart disease (SHD) must be in place.
We face short- and long-term unpredictable consequences, so we must plan ahead the way we are dealing with this challenge and how are we going to resume interventional cardiology procedures, specially TAVI.
Program
|
17:30
|
Regional situation of the cardiovascular impact of COVID-19 pandemic in Europe: overview
Panel roundtable |
| 18:00 |
At the crossroads of COVID-19 and interventional cardiology
Ignacio Cruz Gonzalez
Q&A Session
|
| 18:25 |
Management and monitoring of Mitral regurgitation and other SHD patients: distinctions of patients at risk and practical recommendations
Giuseppe Tarantini
Q&A Session
|
| 18:50 |
Management and monitoring of Aortic Stenosis patients: distinctions of patients at risk and practical recommendations
Nicolas Van Mieghem
Q&A Session |
| 19:30 |
Conclusion
|
Supported by an unrestricted educational grant
Last update : 2022-02-28
